Please wait a minute...
文章检索
预防医学  2020, Vol. 32 Issue (6): 563-568    DOI: 10.19485/j.cnki.issn2096-5087.2020.06.006
  论著 本期目录 | 过刊浏览 | 高级检索 |
直接胆红素和血脂对颈动脉粥样硬化及颈动脉斑块发生风险的交互作用
范为群1, 罗文良2, 邵布勒2, 余运贤2
1.杭州市五云山疗养院,浙江 杭州 310008;
2.浙江大学公共卫生学院
The interaction between direct bilirubin and blood lipids on carotid atherosclerosis and carotid plaque
FAN Weiqun*, LUO Wenliang, SHAO Bule, YU Yunxian
*Hangzhou Wuyunshan Sanatorium,Hangzhou,Zhejiang 310008,China
全文: PDF(597 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析直接胆红素和血脂对颈动脉粥样硬化及颈动脉斑块发生风险的交互作用。方法 选取2016年3月—2018年12月在杭州市五云山疗养院健康体检者为研究对象,收集人口学资料、生化检测和颈动脉超声检查资料,采用多因素多分类Logistic回归模型分析直接胆红素、血脂以及直接胆红素和血脂交互作用对颈动脉粥样硬化和颈动脉斑块发生的影响。结果 共纳入分析8 308人,其中颈动脉粥样硬化616例,占7.41%;颈动脉斑块2 409例,占29.00%。多因素多分类Logistic回归分析结果显示,直接胆红素升高是颈动脉粥样硬化(OR=0.701,95%CI:0.537~0.916)和颈动脉斑块(OR=0.647,95%CI:0.527~0.795)的保护因素;总胆固醇(TC)升高(OR=1.335,95%CI:1.106~1.611)、低密度脂蛋白胆固醇(LDL-C)升高(OR=1.338,95%CI:1.098~1.629)和高密度脂蛋白胆固醇(HDL-C)降低(OR=1.431,95%CI:1.148~1.783)是颈动脉粥样硬化的危险因素;TC升高(OR=1.325,95%CI:1.151~1.525)和LDL-C升高(OR=1.311,95%CI:1.130~1.520)是颈动脉斑块的危险因素。直接胆红素和TC、直接胆红素和LDL-C均对颈动脉斑块发生风险存在交互作用(P<0.05);与直接胆红素升高且TC正常组比较,直接胆红素正常且TC升高组颈动脉斑块发生风险增加(OR=1.831,95%CI:1.438~2.333);与直接胆红素升高且LDL-C正常组比较,直接胆红素正常且LDL-C升高组颈动脉斑块发生风险增加(OR=1.814,95%CI:1.427~2.306)。结论 TC、LDL-C与直接胆红素对颈动脉斑块发生风险存在交互作用,对于直接胆红素水平正常而TC或LDL-C升高患者更应加强血脂控制以预防颈动脉斑块。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
范为群
罗文良
邵布勒
余运贤
关键词 颈动脉粥样硬化颈动脉斑块直接胆红素血脂交互作用    
AbstractObjective To learn the interaction of serum direct bilirubin and blood lipids on the risk of carotid atherosclerosis and carotid plaque. Methods The subjects were selected from Hangzhou Wuyunshan Sanatorium from March 2016 to December 2018. Demographic information,laboratory testing results and carotid intima-media thickness(IMT)were collected. The logistic regression model was employed for the association of direct bilirubin,blood lipids and their interaction with the risk of carotid atherosclerosis and carotid plaque. Results Totally 8 308 subjects were recruited. Among them,616(7.41%) subjects had carotid atherosclerosis,and 2 409(29.00%)subjects had plaques. The results of multivariate and multinomial logistic regression analysis showed that high level of direct bilirubin was associated with decreased risks of carotid atherosclerosis(OR=0.701,95%CI:0.537-0.916)and carotid plaque(OR=0.647,95%CI:0.527-0.795);high TC level(OR=1.335,95% CI:1.106-1.611), high LDL-C level(OR=1.338,95%CI:1.098-1.629)and low HDL-C level(OR=1.431,95%CI:1.148-1.783)were associated with increased risks of carotid atherosclerosis;high TC level(OR=1.325,95% CI:1.151-1.525)and high LDL-C(OR=1.311,95%CI:1.130-1.520)were associated with increased risks of carotid plaque. There were interactions between direct bilirubin and TC or LDL-C on the risk of carotid plaque(P<0.05). Compared with the subjects with high level of direct bilirubin and normal level of TC,the subjects with normal level of direct bilirubin and high level of TC had significantly higher risk of carotid plaque(OR=1.831,95%CI:1.438-2.333);compared with the subjects with high level of direct bilirubin and normal level of LDL-C,the subjects with normal level of direct bilirubin and high level of LDL-C had significantly higher risk of carotid plaque(OR=1.814,95%CI:1.427-2.306).Conclusion The interactions between direct bilirubin and TC or LDL-C increase the risk of carotid plaque. It is important to strengthen blood lipid control in the patients with normal level of direct bilirubin and hyperlipidemia.
Key wordscarotid atherosclerosis    carotid plaque    direct bilirubin    blood lipid    interaction
收稿日期: 2019-10-31      修回日期: 2020-01-07     
中图分类号:  R445  
作者简介: 范为群,本科,副主任医师,主要从事健康管理与预防保健工作
通信作者: 余运贤,E-mail:yunxianyu@zju.edu.cn   
引用本文:   
范为群, 罗文良, 邵布勒, 余运贤. 直接胆红素和血脂对颈动脉粥样硬化及颈动脉斑块发生风险的交互作用[J]. 预防医学, 2020, 32(6): 563-568.
FAN Weiqun, LUO Wenliang, SHAO Bule, YU Yunxian. The interaction between direct bilirubin and blood lipids on carotid atherosclerosis and carotid plaque. Preventive Medicine, 2020, 32(6): 563-568.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2020.06.006      或      http://www.zjyfyxzz.com/CN/Y2020/V32/I6/563
[1] 胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.
[2] 金超,曹中朝.动脉粥样硬化相关因素研究进展[J].现代临床医学,2016,42(3):166-169.
[3] 张斯斯,吴金凤,孟晓萍.颈动脉粥样硬化的重新认识[J].中国临床医生杂志,2015,43(2):18-21.
[4] 李辉,段东辉,王永,等.宁波市居民血脂异常及影响因素分析[J]. 预防医学,2019,31(5):474-478.
[5] ERDOGAN D,GULLU H,YILDIRIM E,et al.Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women[J]. Atherosclerosis,2006,184(2):431-437.
[6] KWO P Y,COHEN S M,LIM J K.ACG clinical guideline:evaluation of abnormal liver chemistries[J].Am J Gastroenterol, 2017,112(1):18-35.
[7] 诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-953.
[8] SIDHU P S,DESAI S R.A simple and reproducible method for assessing intimal-medial thickness of the common carotid artery[J]. Br J Radiol, 1997,70:85-89.
[9] MA H,LIN H,HU Y,et al.Relationship between non-high-density lipoprotein cholesterol and carotid atherosclerosis in normotensive and euglycemic Chinese middle-aged and elderly adults[J].Lipids Health Dis,2017,16(1):5.
[10] THURSTON R C,CHANG Y,VON KÄNEL R,et al.Sleep character ristics and carotid atherosclerosis among midlife women[J/OL].Sleep,2017(2017-01-01)[2020-01-07].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084762/.DOI:10.1093/sleep/zsw052.
[11] BARTON M.Cholesterol and atherosclerosis:modulation by oestrogen[J].Curr Opin Lipidol,2013,24(3):214-220.
[12] FERENCE B A,GINSBERG H N,GRAHAM I,et al.Low-density lipoproteins cause atherosclerotic cardiovascular disease.1.Evidence from genetic,epidemiologic,and clinical studies.A consensus statement from the European Atherosclerosis Society Consensus Panel[J].Eur Heart J,2017,38(32):2459-2472.
[13] KAWAMOTO R,NINOMIYA D,HASEGAWA Y,et al.Mildly elevated serum bilirubin levels are negatively associated with carotid atherosclerosis among elderly persons[J/OL].PLoS One,2014(2014-12-05)[2020-01-07].https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4257609/.DOI:10.1371/journal.pone.0114281.
[14] WEN J,HUANG Y,LU Y,et al.Associations of non-high-density lipoprotein cholesterol,triglycerides and the total cholesterol/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population[J].Hypertens Res,2019,42(8):1223-1230.
[15] YU X H,ZHANG D W,ZHENG X L,et al.Cholesterol transport system:an integrated cholesterol transport model involved in atherosclerosis[J].Prog Lipid Res,2019,73:65-91.
[16] 胡如英,王勇,陈凯伦,等.浙江省农村2型糖尿病患者血脂水平及控制现状[J].预防医学,2019,31(11):1091-1096.
[17] SANDESARA P B,VIRANI S S,FAZIO S,et al.The forgotten lipids: triglycerides,remnant cholesterol,and atherosclerotic cardiovascular disease risk[J].Endocr Rev,2019,40(2):537-557.
[18] VOGEL M E,IDELMAN G,KONANIAH E S,et al.Bilirubin prevents atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice by inhibiting endothelial VCAM-1 and ICAM-1 signaling[J]. J Am Heart Assoc, 2017(2017-04-01)[2020-01-07].https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2836 5565/.DOI:10.1161/JAHA.116.004820.
[19] TAKAHASHI S.Triglyceride rich lipoprotein-LPL-VLDL receptor and Lp(a)-VLDL receptor pathways for macrophage foam cell formation[J].J Atheroscler Thromb,2017,24(6):552-559.
[20] MARUHASHI T,KIHARA Y,HIGASHI Y.Bilirubin and endothelial function[J]. J Atheroscler Thromb,2019,26(8): 688-696.
[21] BULMER A C,VERKADE H J,WAGNER K H.Bilirubin and beyond:a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection[J].Prog Lipid Res,2013,52(2):193-205.
[1] 王盼, 张晓晗, 黄涛. 成年人收缩压与尿酸、血脂、血糖的关联研究[J]. 预防医学, 2023, 35(9): 746-751.
[2] 黄文, 何亮, 傅玲娟, 翁丽霞, 张馨锡, 朱淑霞, 张阳辉, 陈奇峰. 动脉粥样硬化性心血管疾病高危人群血脂控制达标的影响因素研究[J]. 预防医学, 2023, 35(10): 834-839.
[3] 陶寄, 盛敏阳, 许云峰, 孙品晶, 钟节鸣, 王小花. 海宁市居民血脂异常的影响因素分析[J]. 预防医学, 2022, 34(8): 821-825.
[4] 廖红娟, 张援, 宋爱晶, 孙娟, 官凌菊. 广东省成年职业运动员血脂异常调查[J]. 预防医学, 2022, 34(6): 595-599.
[5] 杨娟, 李肖晓, 程蕊蕊, 诸葛瑾慧, 吾孜木·吉格尔, 姚华, 张明琛. 墨玉县成年人群血脂异常调查[J]. 预防医学, 2022, 34(6): 590-594,599.
[6] 呼聪慧, 苏银霞, 阿力米热·阿布迪热依木, 姚华. 墨玉县居民代谢性疾病患病调查[J]. 预防医学, 2022, 34(5): 519-524.
[7] 郑帅印, 李富业, 谢尔瓦妮古丽·阿卜力米提, 李砥. 克拉玛依市35~75岁体检人群高血压、糖尿病、血脂异常调查[J]. 预防医学, 2022, 34(3): 232-239.
[8] 王亮亮, 黄瑜, 郭伟, 魏兴民, 范宁, 赵贵雪, 颉亚辉, 马东京, 王云超, 王新华, 吴建军. 肥胖和中心性肥胖对高血压的交互作用分析[J]. 预防医学, 2022, 34(2): 129-134.
[9] 孙锋, 张磊, 王茜, 袁磊, 刘思浚. 合肥市成年居民血脂异常的影响因素分析[J]. 预防医学, 2022, 34(12): 1251-1256,1261.
[10] 赵瑞, 黄胜楠, 肖暖. 中等强度有氧运动预防高胆固醇血症患者动脉粥样硬化性心血管疾病效果评价[J]. 预防医学, 2022, 34(1): 58-62.
[11] 江南, 余焕玲, 王双. 通州区超重肥胖中小学生血脂异常调查[J]. 预防医学, 2022, 34(1): 87-90.
[12] 张泽鹏, 郭展鹏, 倪钰玥, 富灿涯, 朱梦瑶, 付莹婕, 裘迪红. 植物乳杆菌JX025073.1对小鼠血脂和肠道菌群的调节作用[J]. 预防医学, 2021, 33(9): 893-896.
[13] 江南, 王双, 张雷, 武昌. 通州区中小学生血脂异常调查[J]. 预防医学, 2021, 33(7): 707-710,714.
[14] 王惠根, 王丽春, 盛君霞, 姚超民. 南湖区55岁及以上高血压患者合并高血脂的影响因素分析[J]. 预防医学, 2021, 33(6): 627-630.
[15] 李文丽, 苏银霞, 诸葛瑾慧, 王育珊, 王淑霞, 姚华. 新源县哈萨克族人群主要慢性病的影响因素分析[J]. 预防医学, 2021, 33(4): 398-403.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed